(Q37501033)

20 August 2017

1 reference

title

Hepatic tumors: possible relationship to use of oral contraceptives (English)

1 reference

20 August 2017

Klatskin G

1

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 August 1977

1 reference

full work available at URL

20 August 2017

https://api.elsevier.com/content/article/PII:S001650851932205X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

https://api.elsevier.com/content/article/PII:S001650851932205X?httpAccept=text/plain

28 May 2022

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

28 May 2022

1 reference

20 August 2017

73

1 reference

20 August 2017

386-394

1 reference

20 August 2017

2

1 reference

Letter: liver tumors and oral contraceptives

20 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Ultrastructure of a benign liver cell adenoma

28 May 2022

2

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Ultrastructural findings in a well-differentiated hepatoma.

28 May 2022

3

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Letter: Benign hepatoma in a young woman on contraceptive steroids

28 May 2022

4

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Possible association between benign hepatomas and oral contraceptives.

28 May 2022

5

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Massive hemoperitoneum from rupture of benign hepatocellular adenoma

28 May 2022

6

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Letter: Hepatomas and oral contraceptives

28 May 2022

7

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Letter: Liver hamartomas in patients on oral contraceptives

28 May 2022

Hemoperitoneum from liver cell adenoma in a patient on oral contraceptives

8

0 references

10

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Hepatic Cell Adenomas, Spontaneous Liver Rupture, and Oral Contraceptives

28 May 2022

12

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Clinicopathological conference. A patient's life

28 May 2022

15

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Liver-Cell Adenomas Associated with Use of Oral Contraceptives

28 May 2022

18

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Benign Liver Cell Adenoma Associated With Use of Oral Contraceptive Agents

28 May 2022

19

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Hepatocellular Adenoma: Relationship to Oral Contraceptives?

28 May 2022

21

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Benign hepatic tumors secondary to oral contraceptives

28 May 2022

24

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Association of liver tumors with oral contraceptives

28 May 2022

26

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Letter: Benign hepatomas and oral contraceptives

28 May 2022

27

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Letter: Benign hepatomas and oral contraceptives

28 May 2022

28

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Letter: Benign hepatoma and oral contraceptives.

28 May 2022

29

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Letter: Hepatomas and oral contraceptives.

28 May 2022

30

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Ruptured benign hepatoma associated with an oral contraceptive

28 May 2022

31

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Minimal deviation hepatoma. A new entity

28 May 2022

32

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Benign hepatoma and oral contraceptives

28 May 2022

33

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Focal nodular hyperplasia of the liver. Possible relationship to oral contraceptives

28 May 2022

34

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Letter: Regression of focal nodular hyperplasia after discontinuation of oral contraceptives

28 May 2022

35

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Liver tumors in women on contraceptive steroids

28 May 2022

36

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

28 May 2022

Solitary liver nodules

38

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Focal Nodular Hyperplasia of the Liver and Intrahepatic Hemorrhage in Young Women on Oral Contraceptives

28 May 2022

40

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Focal nodular hyperplasia of the liver, benign hepatomas, oral contraceptives and other drugs affecting the liver

28 May 2022

41

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Hepatic changes in young women ingesting contraceptive steroids. Hepatic hemorrhage and primary hepatic tumors

28 May 2022

42

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Letter: Oral contraceptives and benign liver tumour

28 May 2022

43

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Liver hamartomas in patients on oral contraceptives.

28 May 2022

44

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Spontaneous rupture of the liver caused by hepatomas

28 May 2022

45

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives

28 May 2022

46

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Letter: Oral contraceptives and malignant hepatoma

28 May 2022

47

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Oral contraceptives and malignant hepatoma

28 May 2022

48

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Letter: Hepatoblastoma associated with an oral contraceptive

28 May 2022

50

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Benign Tumors of the Liver

28 May 2022

52

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Standard nomenclature for primary hepatic tumors. A critical need

28 May 2022

53

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Liver-Cell Adenomas and Oral Contraceptives

28 May 2022

54

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Liver-Cell Adenomas and Oral Contraceptives

28 May 2022

55

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Angiographic findings in benign liver cell tumors.

28 May 2022

56

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

28 May 2022

Adenoma of the Liver

57

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Resection of primary liver tumors

28 May 2022

59

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Hepatocellular adenomatosis; report of a case with liver function studies

28 May 2022

60

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Solitary benign adenoma of the liver associated with progressive hepatic insufficiency; report of a case with autopsy findings

28 May 2022

62

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Clinical experiences with major hepatic resections

28 May 2022

64

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Liver-cell adenoma. Angiographic findings and report of a case

28 May 2022

66

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Spontaneous rupture of a hepatic adenoma. A possible hazard of flying

28 May 2022

67

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Hepatic adenoma.Biochemical and electron microscopic study

28 May 2022

68

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Experience with benign tumors of the liver

28 May 2022

69

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Scintillation scanning of liver cell adenoma

28 May 2022

70

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Benign liver cell tumors. Classification and ultrastructural pathology.

28 May 2022

72

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Hepatic cell adenoma: A report of four cases.

28 May 2022

73

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

SURGICAL ASPECTS OF ADENOMA OF THE LIVER

28 May 2022

74

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

28 May 2022

Primary liver tumors

77

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

A case of benign hepatoma

28 May 2022

78

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Hamartomatous cholangiohepatoma; report of a case

28 May 2022

81

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Isolated nodules of regenerative hyperplasia of the liver; the problem of their differentiation from neoplasm

28 May 2022

82

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Focal cirrhosis of the liver: its relation to the so-called hamartoma (adenoma, benign hepatoma).

28 May 2022

83

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Focal nodular hyperplasia of the liver

28 May 2022

85

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Arteriographic findings of focal nodular hyperplasia of the liver and review of the literature

28 May 2022

86

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Focal nodular hyperplasia of the liver. Angiography and radioisotope scanning

28 May 2022

87

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

28 May 2022

Peliosis Hepatis

89

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Peliosis hepatis and cholestasis following administration of norethandrolone

28 May 2022

91

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Peliosis hepatis: Case report and review of pathogenesis

28 May 2022

92

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Peliosis hepatis associated with androgenic-anabolic steroid therapy. A severe form of hepatic injury.

28 May 2022

94

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Letter: Peliosis hepatis after long-term administration of oxymetholone

28 May 2022

95

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Letter: Liver-cell carcinoma after long-term oestrogen-like drugs

28 May 2022

98

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Primary liver cancer associated with long-term oestrogen therapy

28 December 2022

99

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma

28 December 2022

100

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Androgenic-anabolic steroid therapy and hepatocellular carcinoma

28 December 2022

101

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Androgen-induced hepatoma

28 December 2022

102

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Hepatic adenoma in Fanconi anemia treated with oxymetholone

28 December 2022

103

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Letter: Liver lesions and androgenic steroid therapy

28 December 2022

104

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Effects of the antifertility drug enovid in five strains of mice, with particular regard to carcinogenesis.

28 December 2022

105

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

Letter: Liver-cell neoplasms and oral contraceptives

28 December 2022

107

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(19)32205-X

28 December 2022

Identifiers

1 reference